global-alert
global messaging alerts

Expert Content LibraryData Sheets


ApiJect Company Profile

WHO WE ARE

ApiJect Systems, Corp. (ApiJect) is a medical technology company that seeks to improve how companies fill-finish injectable medicines. We do this by working with pharma partners to design rapidly-scalable, cost-efficient drug delivery systems, and when approved by regulators, will assist them in manufacturing those devices at their facilities or a trusted CMO/CDMO.

OUR TECHNOLOGY

The ApiJect Design Platform brings together aseptic Blow-Fill-Seal (BFS) drug packaging with connectable components to create high-quality, prefilled drug delivery systems that can be made at development and commercial scale. And our temperature managed BFS technology expands the range of products that BFS can fill-finish to potentially include temperature-sensitive biologics and vaccines.

OUR SERVICES

  • BFS process evaluation
  • Customized BFS container and delivery system designs to suit specific drug needs
  • Technology and BFS mold licensing to CMO/CDMO or pharma partner
  • Prototype development for drug delivery systems
  • Delivery system manufacturing for both small and large scale
  • Modular BFS production line support
  • Ongoing fill-finish support for our drug delivery systems and molds

PREFILLED DRUG DELIVERY SYSTEMS

We work with pharma partners to design highly-scalable and cost effective drug delivery systems based on the drug product’s needs. Our drug delivery systems are designed as the combination of multiple, easily-attachable components, which allows for easy transport as well as scalable and economical manufacturing. This can be seen in our first drug delivery system, the Prefilled ApiJect Injector*, which is designed to bring together a BFS container and needle hub to create an inline BFS prefilled syringe.

BFS SOLUTIONS FOR COMPLEX PRODUCTS

BFS is an industry-recognized advanced aseptic filling process and is trusted globally to package 50 billion units annually. A wide range of small and large molecules, including vaccines, have been successfully tested and packaged in BFS for opthalmic, oral, and parenteral administration. ApiJect is expanding the range of biologics and other liquid injectables that BFS can fill with our temperature management technology.

CURRENT R&D

ApiJect has a strong committment to R&D. Our device and manufacturing teams are inventing new ways to bring together modular manufacturing,
BFS, and interconnecting device design to help more drug products reach more patients safely.

LOCATIONS

Our headquarters are in Stamford, CT and we have offices in the United States, Great Britain, South Korea and Switzerland.

FOR MORE INFORMATION:

Blow-Fill-Seal: visit https://bit.ly/3l27Qwy
Expert Content Library: visit https://bit.ly/3IZrEZm
Manufacturing: visit https://bit.ly/3YwKiOc
Company Profile: visit https://bit.ly/3ZZya9F
Email: [email protected]


ApiJect Systems, Corp.
2 High Ridge Park, Stamford, CT 06905
Phone: (203) 998-6176
Email: [email protected].

 

Social media & sharing icons powered by UltimatelySocial
Twitter
YouTube
YouTube
LinkedIn
LinkedIn